The Pharmacopoeial Discussion Group (PDG) is excited to announce the launch of the next phase of its global expansion initiative aimed at increasing convergence of harmonised pharmacopoeial standards. This initiative will be the start of a process over the next couple of years to welcome additional pharmacopoeias as new members.
Pharmacopoeias interested in becoming members are encouraged to review the entry criteria, framework and reference information. They are required to submit a statement of intent to the PDG by 15 September 2024 and the formal application by 31 December 2024.
Founded in 1989, the PDG brings together pharmacopoeias to harmonise excipient monographs and selected general texts. Last year, the founding members – the European Pharmacopoeia (Ph. Eur.), the Japanese Pharmacopoeia (JP) and the United States Pharmacopeia (USP) – welcomed the Indian Pharmacopoeia Commission (IPC) as the fourth member. The IPC joining the PDG marked the culmination of a pilot programme launched in 2022 which laid the groundwork for this global initiative.
The PDG has successfully harmonised and maintains 31 general chapters, including key analytical procedures such as chromatography, dissolution testing, sterility and microbiological examination. In addition, the PDG has harmonised 48 excipient monographs and has approximately 20 new texts in its pipeline (general chapters, excipients). The PDG remains committed to promoting the recognition of harmonised pharmacopeial standards to achieve global convergence.
The PDG invites all interested world pharmacopoeias to visit the website for further information regarding the PDG and ensure potential applicants meet the entry criteria.
See also: